Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancerfor Breast Cancer451 locations incl. FairbanksSponsor: Canadian Cancer Trials GroupSex: Female·Age: 35+Code: NCT03488693·Phase 3·RecruitingApply to this trial
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Studyfor Lumbar Spinal Stenosis2306 locations incl. AthensSponsor: Stryker InstrumentsSex: All·Age: 18+Code: NCT03072927·RecruitingApply to this trial
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancerfor Oropharyngeal p16INK4a-Negative Squamous Cell CarcinomaDrug: Atezolizumab338 locations incl. BirminghamSponsor: National Cancer Institute (NCI)Sex: All·Age: 18+Code: NCT01810913·Phase 2, Phase 3·RecruitingApply to this trial
Quantitative MRI Assessment of Breast Cancer Therapy Responsefor Breast Cancer4 locations incl. Iowa CitySponsor: Corewell Health EastSex: All·Age: 18+Code: NCT05704062·RecruitingApply to this trial